News

The powerhouse team wants to use data to help patients and providers.

Doximity drew upon its vast network of physicians to undertake the study of language barriers in healthcare.

Both companies said they expected to further collaborate with other companies in the crowding telehealth space.

The Integrated Health Model Initiative aspires to improve data practices to strengthen care.

No, it's not Craigslist. It's technology, gamification, and telehealth.

A report from McAfee Labs found that the industry suffered the most security incidents of the 2nd quarter.

Data scientists, doctors, and marketing departments disagree on the potential of artifical intelligence for medicine.

“In theory, the methodology could apply to any medical conditions, as long as we could have enough training data.”

A study found ophthalmologists spent 3.7 hours per day in the system.

How they hope to safeguard patient information on the Internet of Medical Things.

What about the human-like computer made veterans more likely to discuss PTSD symptoms?

A new study of brain imaging results reiterates the need to focus on gathering quality information.

Researchers used whole genome sequencing to identify a genetic signature for the disorder.

Why the trade group wants integration, standardization, and participation from all stakeholders.

And, surprisingly, so do traditional reminder letters.

From hand sanitizer use to monitoring chronic conditions, hospitals can find novel ways to harness the power of AI, according to a new report.

Why the website’s banking on crowdsourced trial predictions, data visualizations, and community.

"They’re actually, in my opinion, driving people from the best doctors to the nicest doctors. Is there value in that?"

Qiagen and Centogene AG hope to use sprawling data sets and AI to improve clinical prediction.

Less than 30 percent of hospitals got where they needed to be in 2015. But why?

A doctor and CEO explains how telemedicine can improve hospital care as the number of non-physician clinicians rises.

Lessons from GlaxoSmithKline’s app-based study can benefit healthcare companies.

After hitting 3 key goals, GlaxoSmithKline’s PARADE could help change data collection.

What needs to happen before Alexa answers questions about your meds?

More often than you might think, panelists said. But only for the right reasons.

Risk is inherent, one Takeda exec said. But the potential is clear.

The buyer touted the lab company's "unique epigenetic technology and expertise."

Takeda Pharmaceuticals uses this rubric to know what it’s getting into. You can, too.